Simvastatin Ameliorates Lipid Metabolism-Mediated Endothelial Inflammation and Tight Junction Impairment in Chronic Cerebral Hypoperfusion

Key Points

• Simvastatin significantly decreases endothelial inflammation and improves tight junction integrity during chronic cerebral hypoperfusion.
• Blood-brain barrier functions may be strengthened as simvastatin enhances lipid metabolism and reduces inflammation.
• Assessment using biomarkers indicates beneficial biochemical changes after simvastatin treatment in vascular health.
• Supporting evidence suggests simvastatin could play a role in preventing neurovascular dysfunction in chronic conditions.